THE SPECTRUM OF ACTION OF NEW IMMUNOSUPPRESSIVE DRUGS

被引：0

作者：

THOMSON, AW ^{[1
]}

机构：

[1] UNIV PITTSBURGH,MED CTR,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15213

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1992年 / 89卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：170 / 173

页数：4

共 50 条

[41] RENAL-TRANSPLANTATION FOR THE NEPHROLOGIST - NEW IMMUNOSUPPRESSIVE DRUGS
FIRST, MR
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (01) : 3 - 9
[42] CYCLOSPORIN (CYCLOSPORIN A) - PROTOTYPE OF A NEW GENERATION OF IMMUNOSUPPRESSIVE DRUGS
BENDTZEN, K
ALLERGY, 1984, 39 (08) : 565 - 571
[43] MODE OF ACTION OF CYCLOSPORIN-A - NEW IMMUNOSUPPRESSIVE AGENT
WHITE, DJG
CALNE, RY
PLUMB, A
TRANSPLANTATION PROCEEDINGS, 1979, 11 (01) : 855 - 859
[44] Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays
Barten, MJ
Gummert, JF
van Gelder, T
Shorthouse, R
Morris, RE
TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2119 - 2120
[45] New immunosuppressive drugs for prevention and treatment of rejection in renal transplant
Segoloni, Giuseppe P.
Quaglia, Marco
JOURNAL OF NEPHROLOGY, 2006, 19 (05) : 578 - 586
[46] New developments in immunosuppressive drugs in the field of renal transplantation - Foreword
Philipp, T
Heemann, U
CLINICAL NEPHROLOGY, 1996, 45 (05) : 325 - 325
[47] Is it possible to reduce the number of endomyocardial biopsies with new immunosuppressive drugs?
Lage, E.
Ballesteros, S.
Mogollon, M. V.
Ordonez, A.
Gomez, S.
Hernandez, A.
Hinojosa, R.
TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2544 - 2546
[48] MUTAGENICITY OF THE NEW IMMUNOSUPPRESSIVE DRUGS, FK-506, AND SPERGUALIN
YU, Y
YUZAWA, K
OTSUKA, M
FUKAO, K
TRANSPLANTATION PROCEEDINGS, 1993, 25 (02) : 2116 - 2118
[49] NEW IMMUNOSUPPRESSIVE DRUGS - MECHANISTIC INSIGHTS AND POTENTIAL THERAPEUTIC ADVANCES
THOMSON, AW
STARZL, TE
IMMUNOLOGICAL REVIEWS, 1993, 136 : 71 - 98
[50] Quality assessment issues of new immunosuppressive drugs and experimental experience
Holt, DW
Jones, K
Lee, T
Stadler, P
Johnston, A
THERAPEUTIC DRUG MONITORING, 1996, 18 (04) : 362 - 367

← 1 2 3 4 5 →